Financials
| Renalytix Reports Financial Results for Q3 FY2024 | May. 15, 2024 |
| Half Year Report | Feb. 15, 2024 |
| Announcement of AGM and Publication of AR | Oct. 30, 2023 |
| Renalytix Reports Full Year Fiscal 2023 Results | Sep. 28, 2023 |
| Financial Results for Q3 of Fiscal Year 2023 | Jun. 09, 2023 |
| Half-year Report | Mar. 30, 2023 |
| Results for First Quarter of Fiscal Year 2023 | Nov. 30, 2022 |
Proxies
| Result of AGM | Dec. 15, 2023 |
| Publication of Annual Report 2023 & Notice of AGM | Nov. 17, 2023 |
| Result of AGM | Dec. 19, 2022 |
| Result of AGM | Dec. 17, 2021 |
Ownership Update
| Holding(s) in Company | Jul. 10, 2024 |
| PDMR Dealing | Jun. 13, 2024 |
| Holding(s) in Company | May. 14, 2024 |
| Holding(s) in Company | May. 14, 2024 |
| Holding(s) in Company | May. 01, 2024 |
| Holding(s) in Company | Apr. 30, 2024 |
| Holding(s) in Company | Apr. 26, 2024 |
Announcements
| Issue of Shares and Rule 2.9 Announcement | Jul. 15, 2024 |
| Steno Diabetes Center (Copenhagen) Collaboration | Jul. 11, 2024 |
| Admission of the Second Tranche Placing Shares | Jul. 01, 2024 |
| Nasdaq Delisting Determination - Appeal update | Jun. 28, 2024 |
| Total Voting Rights | Jun. 28, 2024 |
| Change of public accounting firm | Jun. 25, 2024 |
| Receipt of Nasdaq Delisting Determination - Appeal | Jun. 25, 2024 |